Showing results (671-680 of 763) with videos related to
Sort By:
Pageof 77
The Journal of Cell Biology|July 18, 2020
EGF receptor-mediated FUS phosphorylation promotes its nuclear translocation and fibrotic signalingManuel Chiusa, Wen Hu, Jozef Zienkiewicz, et al.Lancet (London, England)|August 11, 2004
Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trialGiuseppe Remuzzi, Mariadomenica Lesti, Eliana Gotti, et al.Journal of the American Society of Nephrology : JASN|April 12, 2014
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyDick de Zeeuw, Blai Coll, Dennis Andress, et al.Lancet (London, England)|September 28, 2025
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 studyDavid Kavanagh, Andrew S Bomback, Marina Vivarelli, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2015
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic NephropathyDonald E Kohan, Hiddo J Lambers Heerspink, Blai Coll, et al.Diabetes, Obesity & Metabolism|December 17, 2016
Comparison of exposure response relationship of atrasentan between North American and Asian populationsHiddo J L Heerspink, Hirofumi Makino, Dennis Andress, et al.Kidney International Reports|February 24, 2025
Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 GlomerulopathyCarla M Nester, Ute Eisenberger, Alexandre Karras, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 20, 2012
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo armHicham Skali, Julie Lin, Marc A Pfeffer, et al.Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.Lancet (London, England)|April 18, 2016
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional studyRavindra L Mehta, Emmanuel A Burdmann, Jorge Cerdá, et al.Pageof 77